Mathematical modelling of survival of glioblastoma patients suggests a role for radiotherapy dose escalation and predicts poorer outcome after delay to start treatment

NG Burnet, R Jena, SJ Jefferies, SP Stenning… - Clinical Oncology, 2006 - Elsevier
AIMS: The outcome of patients with glioblastoma (GBM) remains extremely poor. We have
developed a mathematical model, using pathological and radiation biology concepts, to …

Mathematical modelling of survival of glioblastoma patients suggests a role for radiotherapy dose escalation and predicts poorer outcome after delay to start treatment.

NG Burnet, R Jena, SJ Jefferies… - … (Royal College of …, 2006 - europepmc.org
Aims The outcome of patients with glioblastoma (GBM) remains extremely poor. We have
developed a mathematical model, using pathological and radiation biology concepts, to …

Mathematical modelling of survival of glioblastoma patients suggests a role for radiotherapy dose escalation and predicts poorer outcome after delay to start treatment

NG Burnet, R Jena, SJ Jefferies… - … (Royal College of …, 2006 - pubmed.ncbi.nlm.nih.gov
Aims The outcome of patients with glioblastoma (GBM) remains extremely poor. We have
developed a mathematical model, using pathological and radiation biology concepts, to …

Mathematical Modelling of Survival of Glioblastoma Patients Suggests a Role for Radiotherapy Dose Escalation and Predicts Poorer Outcome After Delay to Start …

NG Burnet, R Jena, SJ Jefferies, SP Stenning… - Clinical Oncology, 2006 - infona.pl
The outcome of patients with glioblastoma (GBM) remains extremely poor. We have
developed a mathematical model, using pathological and radiation biology concepts, to …

Mathematical Modelling of Survival of Glioblastoma Patients Suggests a Role for Radiotherapy Dose Escalation and Predicts Poorer Outcome After Delay to Start …

NG Burnet, R Jena, SJ Jefferies… - Clinical …, 2006 - clinicaloncologyonline.net
Aims The outcome of patients with glioblastoma (GBM) remains extremely poor. We have
developed a mathematical model, using pathological and radiation biology concepts, to …

Mathematical modelling of survival of glioblastoma patients suggests a role for radiotherapy dose escalation and predicts poorer outcome after delay to start treatment

NG Burnet, R Jena, SJ Jefferies… - CLINICAL …, 2006 - openresearch.surrey.ac.uk
Science & Technology Life Sciences & Biomedicine Oncology ONCOLOGY delay to start
treatment glioblastoma Monte Carlo mathematical modelling radiotherapy dose escalation …

Mathematical modelling of survival of glioblastoma patients suggests a role for radiotherapy dose escalation and predicts poorer outcome after delay to start treatment

NG Burnet, R Jena, SJ Jefferies… - Clinical …, 2006 - research.manchester.ac.uk
Aims The outcome of patients with glioblastoma (GBM) remains extremely poor. We have
developed a mathematical model, using pathological and radiation biology concepts, to …

Mathematical modelling of survival of glioblastoma patients suggests a role for radiotherapy dose escalation and predicts poorer outcome after delay to start treatment

NG Burnet, R Jena, SJ Jefferies… - CLINICAL …, 2006 - openresearch.surrey.ac.uk
Science & Technology Life Sciences & Biomedicine Oncology ONCOLOGY delay to start
treatment glioblastoma Monte Carlo mathematical modelling radiotherapy dose escalation …

[引用][C] Mathematical modelling of survival of glioblastoma patients suggests a role for radiotherapy dose escalation and predicts poorer outcome after delay to start …

NG BURNET, R JENA, SJ JEFFERIES, SP STENNING… - Clinical oncology, 2006 - Elsevier